Results 11 to 20 of about 19,614 (168)

Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against Acinetobacter baumannii complex clinical isolates

Microbiology Spectrum, 2023
The aim of this study was to evaluate the correlation between inhibitory zones and minimum inhibitory concentrations (MICs) when testing cefiderocol against Acinetobacter baumannii complex using disk diffusion and the broth microdilution (BMD) method ...
Yanling Liu, Li Ding, Renru Han, Lingbing Zeng, Junming Li, Yan Guo, Fupin Hu   +6 more
doaj   +1 more source

EUCAST Technical Note on voriconazole [PDF]

Clinical Microbiology and Infection, 2008
Contains fulltext : 70467.pdf (Publisher’s version ) (Open Access)
Rodriguez-Tudela, J.L., Donnelly, J.P., Arendrup, M.C., Arikan, S., Barchiesi, F., Bille, J., Chryssanthou, E., Cuenca-Estrella, M., Danaoui, E., Denning, D.W., Fegeler, W., Gaustad, P., Lass-Florl, C., Moore, C., Richardson, M., Schmalreck, A., Velegraki, J.A., Verweij, P.E.   +17 more
openaire   +3 more sources

Aspergillus Section Terrei and Antifungals: From Broth to Agar-Based Susceptibility Testing Methods

Journal of Fungi, 2023
Providing timely antifungal treatment to patients suffering from life-threatening invasive fungal infections (IFIs) is essential. Due to the changing epidemiology and the emergence of antifungal resistance in Aspergillus, the most commonly responsible ...
Roya Vahedi-Shahandashti, Lisa Hahn, Jos Houbraken, Cornelia Lass-Flörl   +3 more
doaj   +1 more source

Instruction videos from EUCAST [PDF]

JAC-Antimicrobial Resistance, 2020
Graphical Abstract.
openaire   +2 more sources

Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital

Antimicrobial Resistance and Infection Control, 2022
Background We previously reported an increase in meropenem prescriptions for Pseudomonas aeruginosa infections in our hospital after the implementation of the 10th version of the EUCAST breakpoints table for P. aeruginosa in January 2020.
Aline Munting, José Damas, Benjamin Viala, Guy Prod’hom, Benoit Guery, Laurence Senn   +5 more
doaj   +1 more source

EUCAST Technical note on Amphotericin B [PDF]

Clinical Microbiology and Infection, 2011
The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for amphotericin B for Candida spp. This Technical Note is based on the EUCAST amphotericin B rationale document (available on the EUCAST website: http://www.eucast.org).
Lass-Florl, C., Arendrup, M.C., Rodriguez-Tudela, J.L., Cuenca-Estrella, M., Donnelly, P., Hope, W.   +5 more
openaire   +2 more sources

Candida albicans and Candida dubliniensis Show Different Trailing Effect Patterns When Exposed to Echinocandins and Azoles

Frontiers in Microbiology, 2020
When Candida albicans and Candida dubliniensis isolates were tested for susceptibility to fluconazole and echinocandins using either EUCAST or Etest methods, differential patterns of growth were observed, independently of the methods used.
Rania Ayadi, Emilie Sitterlé, Emilie Sitterlé, Christophe d’Enfert, Eric Dannaoui, Eric Dannaoui, Marie-Elisabeth Bougnoux, Marie-Elisabeth Bougnoux   +7 more
doaj   +1 more source

In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015–2018

Journal of Global Antimicrobial Resistance, 2021
Objectives: To report antimicrobial susceptibility testing surveillance data for ceftaroline and comparative agents from the AWARE global surveillance programme for bacterial pathogens causing skin and soft tissue infections (SSTIs) and lower respiratory
James A. Karlowsky, Meredith A. Hackel, Samue l K. Bouchillon, Warren Lowman, Ramy El Mahdy Kotb, Naglaa Mohamed, Gregory G. Stone, Daniel F. Sahm   +7 more
doaj   +1 more source

PERFORMANCE OF EUCAST RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING (RAST) FOR SCREENING EXTENDED-SPECTRUM Β-LACTAMASE (ESBL), CARBAPENEMASES IN ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE USING POSITIVE BLOOD CULTURE BROTHS

International Journal of Infectious Diseases, 2023
Intro: Rapid reporting of Antimicrobial susceptibility testing (AST) of blood culture (BC) isolates is critical to optimize therapy. The standard turnaround time (TAT) for identification and AST using conventional disc diffusion (DD) is 48-96 hours after
A. Bhatnagar, R. Gaind
doaj   +1 more source

EUCAST expert rules in antimicrobial susceptibility testing [PDF]

Clinical Microbiology and Infection, 2013
EUCAST expert rules have been developed to assist clinical microbiologists and describe actions to be taken in response to specific antimicrobial susceptibility test results. They include recommendations on reporting, such as inferring susceptibility to other agents from results with one, suppression of results that may be inappropriate, and editing of
Leclercq, R., Cantón, R., Brown, D. F. J., Giske, C. G., Heisig, P., Macgowan, A. P., Mouton, J. W., Nordmann, P., Rodloff, A. C., ROSSOLINI, GIAN MARIA, Soussy, C. J., Steinbakk, M., Winstanley, T. G., Kahlmeter, G.   +13 more
openaire   +5 more sources